CAMBRIDGE, Mass.--(BUSINESS WIRE)--Feb. 10, 2009--
Alkermes, Inc. (NASDAQ: ALKS) announced today that its corporate
presentation will be webcast live by Roth Capital on Tuesday, February
17, 2009 at 1:30 p.m. PST (4:30 p.m. EST). The presentation will be
webcast from the Ritz-Carlton Laguna Niguel in Dana Point, California
and may be accessed under the investor relations tab at www.alkermes.com.
The presentation will be archived for 14 days.
Alkermes, Inc. is a fully integrated biotechnology company committed to
developing innovative medicines to improve patients' lives. Alkermes
developed, manufactures and commercializes VIVITROL® for
alcohol dependence and manufactures RISPERDAL® CONSTA®
for schizophrenia. Alkermes' robust pipeline includes extended-release
injectable, pulmonary and oral products for the treatment of prevalent,
chronic diseases, such as central nervous system disorders, addiction
and diabetes. Headquartered in Cambridge, Massachusetts, Alkermes has
research facilities in Massachusetts and a commercial manufacturing
facility in Ohio.
Source: Alkermes, Inc.
Alkermes, Inc.
Eva Stroynowski, 617-583-6823
Corporate
Communications